[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ZA200804664B - Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt - Google Patents

Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt

Info

Publication number
ZA200804664B
ZA200804664B ZA200804664A ZA200804664A ZA200804664B ZA 200804664 B ZA200804664 B ZA 200804664B ZA 200804664 A ZA200804664 A ZA 200804664A ZA 200804664 A ZA200804664 A ZA 200804664A ZA 200804664 B ZA200804664 B ZA 200804664B
Authority
ZA
South Africa
Prior art keywords
pyrrol
fluorophenyl
dihydroxy
carbonyl
isopropyl
Prior art date
Application number
ZA200804664A
Inventor
Kaul Vijay
Yadav Gyan Chand
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of ZA200804664B publication Critical patent/ZA200804664B/en

Links

ZA200804664A 2005-11-08 2008-05-29 Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt ZA200804664B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2964DE2005 2005-11-08

Publications (1)

Publication Number Publication Date
ZA200804664B true ZA200804664B (en) 2009-04-29

Family

ID=40114304

Family Applications (3)

Application Number Title Priority Date Filing Date
ZA200804666A ZA200804666B (en) 2005-11-08 2008-05-29 Pharmaceutical combination
ZA200804665A ZA200804665B (en) 2005-11-08 2008-05-29 Process for preparation of (3R, 5R)-7-[2-(4-fluorophenly)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
ZA200804664A ZA200804664B (en) 2005-11-08 2008-05-29 Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ZA200804666A ZA200804666B (en) 2005-11-08 2008-05-29 Pharmaceutical combination
ZA200804665A ZA200804665B (en) 2005-11-08 2008-05-29 Process for preparation of (3R, 5R)-7-[2-(4-fluorophenly)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt

Country Status (2)

Country Link
CN (3) CN101304968A (en)
ZA (3) ZA200804666B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102013157B1 (en) * 2015-03-31 2019-08-23 대원제약주식회사 Crystalline form and Method of preparing the same
KR102218320B1 (en) * 2019-07-12 2021-02-23 대원제약주식회사 Method of preparing(3r,5r)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-((4-hydroxymethylphenylamino)carbonyl)-pyrrol-1-yl)-3,5-dihydroxy-heptanoic acid hemi calcium salt, and method of preparing intermediates used therein
CN111494369B (en) * 2020-05-27 2022-07-01 上海市第五人民医院 Compound pharmaceutical composition for coronary heart disease
CN113143916A (en) * 2021-04-28 2021-07-23 苏州大学 Application of Batimastat in preparation of medicine for preventing and treating obesity and secondary bone loss

Also Published As

Publication number Publication date
CN101304967A (en) 2008-11-12
ZA200804665B (en) 2009-07-29
CN101304968A (en) 2008-11-12
CN101304744A (en) 2008-11-12
ZA200804666B (en) 2010-01-27
CN101304967B (en) 2011-10-05

Similar Documents

Publication Publication Date Title
SG166829A1 (en) Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
ZA200806066B (en) Process for the preparation of 6,6-dimethyl-3-azabicyclo[3.1.0]-hexane compounds and enantiomeric salts thereof
IL192242A0 (en) Improved process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides
ZA200705872B (en) Indole derivatives for treating viral infections
SMT201400142B (en) N- (1H-indazol-4-yl) immidazo [1,2-A] pyridin-3-carboxamide compounds substituted as cfms inhibitors
AP2007004128A0 (en) Tricyclic-nucleoside compounds for treating viral infections
ATE451363T1 (en) 3-(INDAZOL-5-YL)-(1,2,4)TRIAZINE DERIVATIVES AND RELATED COMPOUNDS AS PROTEIN KINASE INHIBITORS FOR THE TREATMENT OF CANCER
IL186526A0 (en) Substituted amide derivatives as protein kinase inhibitors
PL1882684T3 (en) Pyrrolidine derivative or salt thereof
ATE447559T1 (en) 4-(PHENYLAMINO)-6-OXO-1,6-DIHYDROPYRIDAZINE-3- CARBOXAMIDE DERIVATIVES AS MEK INHIBITORS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES
IL192241A0 (en) Improved process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof
DE602006017980D1 (en) 3,4-SUBSTITUTED PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF HYPERTONIA
GB2431927A9 (en) 1,2-Disubstituted indoles & derivatives thereof astherapeutic 5-iipoxygenase-activating protein (fl ap) inhibitors
EP1877055A4 (en) 4-aminoquinoline compounds for treating virus-related conditions
TW200736195A (en) Methods for preparing sulfonamide substituted alcohols and intermediates thereof
SI1860098T1 (en) Novel anthranilic acid derivative or salt thereof
IL184885A0 (en) 7-{4-[2-(2,6-dihydro-4-methylphenoxy)ethoxyl]phenyl}-3,9-diazabicyclo[3.3.31]non-6-ene-s-carboxylic acid cyclopropyl-(2,3-dimethylbenzyd amide as inhibitors of renin for the treatment of hypertension
DE602006019710D1 (en) MAGNESIUM SALT OF HMG COA REDUCTASE INHIBITORS
EP1926725A4 (en) Alkoxy indolinone based protein kinase inhibitors
ZA200804664B (en) Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
IL190729A0 (en) Methods for preparing glutamic acid derivatives
AP2007004270A0 (en) Process for preparing salts of hydrocyanic acid
WO2008010087A3 (en) Polymorphic forms of an hmg-coa reductase inhibitor and uses thereof
EP1853558A4 (en) Process for producing atorvastatin hemicalcium
EP1893194A4 (en) Enhanced indolinone based protein kinase inhibitors